Paper Details

  1. Home
  2. Paper Details

Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.

Author: CookKatie, GalaiNoya, GlassSheldon, LucasGregory M, McCaulMary E, MooreRichard D, MullenBernadette Anna, OurslerKrisann K, RandCynthia

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This study investigates the potential of directly administered antiretroviral therapy (DAART) delivered in opioid treatment programs (OTPs) to improve viral suppression rates in HIV-infected drug users.
Paper Details　
Original Abstract of the Article :
HIV-infected drug users are at higher risk of non-adherence and poor treatment outcomes than HIV-infected non-drug users. Prior work from our group and others suggests that directly administered antiretroviral therapy (DAART) delivered in opioid treatment programs (OTPs) may increase rates of viral ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047295/

データ提供：米国国立医学図書館（NLM）

Directly Administered Antiretroviral Therapy: A New Approach for HIV-Infected Drug Users

HIV infection is a serious health concern, particularly for individuals who use drugs. This study explores the potential of directly administered antiretroviral therapy (DAART) as a way to improve treatment outcomes for HIV-infected drug users who are enrolled in opioid treatment programs (OTPs). The researchers investigated the feasibility and potential benefits of DAART in this high-risk population.

DAART: A Beacon of Hope for Improved Adherence

The study aimed to recruit participants for a randomized controlled trial of DAART in OTPs. This trial aims to determine if DAART can improve rates of viral suppression in this vulnerable population. It's like providing a reliable oasis for weary travelers—DAART could offer a path to improved adherence and better health outcomes.

The Power of Collaboration: A Holistic Approach to HIV Care

This research highlights the importance of collaboration between HIV care providers and OTPs. By working together, they can provide comprehensive and integrated care to HIV-infected drug users, addressing both their substance use and their HIV infection. It's like a caravan crossing the desert—we need a team effort to ensure a successful journey.

Dr.Camel's Conclusion

This study offers hope for a new approach to HIV care for drug users, potentially improving treatment outcomes and supporting a healthier future. It's like finding a new path through the desert, leading to a brighter oasis of health.

Date :
  1. Date Completed 2011-06-07
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

21324133

DOI: Digital Object Identifier

PMC3047295

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.